{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:06:00Z","timestamp":1772809560883,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ekir.2020.10.035","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T02:17:54Z","timestamp":1604974674000},"page":"501-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD"],"prefix":"10.1016","volume":"6","author":[{"given":"Sandawana William","family":"Majoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geetha","family":"Rathnayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Barzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaquelyne T.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Cass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2020.10.035_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12882-017-0791-3","article-title":"Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources","volume":"19","author":"Li","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1071\/AH16156","article-title":"Projecting demands for renal replacement therapy in the Northern Territory: a stochastic Markov model","volume":"42","author":"You","year":"2018","journal-title":"Aust Health Rev"},{"key":"10.1016\/j.ekir.2020.10.035_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ckj\/sfu109","article-title":"Kidney disease in Aboriginal Australians: a perspective from the Northern Territory","volume":"7","author":"Hoy","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2020.10.035_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/nep.12798","article-title":"An expanded nationwide view of chronic kidney disease in Aboriginal Australians","volume":"21","author":"Hoy","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2020.10.035_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/hdi.12173","article-title":"Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia","volume":"18","author":"Majoni","year":"2014","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","article-title":"Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018","volume":"71","author":"Fishbane","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1523-1755.2005.00554.x","article-title":"Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease","volume":"68","author":"Rao","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/sj.ki.5000105","article-title":"Association of anemia with outcomes in men with moderate and severe chronic kidney disease","volume":"69","author":"Kovesdy","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10157-017-1468-8","article-title":"Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease","volume":"22","author":"Sato","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084943","article-title":"Prevalence of anemia in chronic kidney disease in the United States","volume":"9","author":"Stauffer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.10.035_bib11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mcna.2004.12.004","article-title":"Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease","volume":"89","author":"Pendse","year":"2005","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ekir.2020.10.035_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3346\/jkms.2017.32.2.249","article-title":"The prevalence and management of anemia in chronic kidney disease patients: result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)","volume":"32","author":"Ryu","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.ekir.2020.10.035_bib14","doi-asserted-by":"crossref","first-page":"h2258","DOI":"10.1136\/bmj.h2258","article-title":"Management of anaemia in chronic kidney disease: summary of updated NICE guidance","volume":"350","author":"Padhi","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2020.10.035_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMe1215043","article-title":"Anemia treatment in patients with chronic kidney disease","volume":"368","author":"Dr\u00fceke","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ki.2008.299","article-title":"Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"74","author":"Locatelli","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) Controversies Conference","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib19","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/ckj\/sfx043","article-title":"Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions","volume":"10","author":"Macdougall","year":"2017","journal-title":"Clin Kidney J"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib20","first-page":"S78","article-title":"Iron deficiency anemia in chronic kidney disease: uncertainties and cautions","volume":"21","author":"Agarwal","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000485314","article-title":"Improving erythropoiesis stimulating agent hyporesponsiveness in hemodialysis patients: the role of hepcidin and hemodiafiltration online","volume":"45","author":"Rosati","year":"2018","journal-title":"Blood Purif"},{"key":"10.1016\/j.ekir.2020.10.035_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.035_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-010-8199-1","article-title":"The role of iron in the immune response to bacterial infection","volume":"50","author":"Cherayil","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.ekir.2020.10.035_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.ajkd.2015.11.012","article-title":"Diagnosis and management of iron deficiency in CKD: a summary of the NICE guideline recommendations and their rationale","volume":"67","author":"Ratcliffe","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients","volume":"13","author":"Feldman","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2013.08.001","article-title":"Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD","volume":"62","author":"Moist","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/nep.12139","article-title":"KHA-CARI Guideline: use of iron in chronic kidney disease patients","volume":"18","author":"Macginley","year":"2013","journal-title":"Nephrology (Carlton)"},{"issue":"suppl 6","key":"10.1016\/j.ekir.2020.10.035_bib28","doi-asserted-by":"crossref","first-page":"1559s","DOI":"10.3945\/ajcn.117.155804","article-title":"Current understanding of iron homeostasis","volume":"106","author":"Anderson","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ekir.2020.10.035_bib29","series-title":"WHO Guideline on Use of Ferritin Concentrations to Assess Iron Status in Individuals and Populations","year":"2020"},{"key":"10.1016\/j.ekir.2020.10.035_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000493551","article-title":"Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data","volume":"48","author":"Macdougall","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib31","doi-asserted-by":"crossref","first-page":"7692376","DOI":"10.1155\/2020\/7692376","article-title":"The impact of CKD anaemia on patients: incidence, risk factors, and clinical outcomes\u2014a systematic literature review","volume":"2020","author":"Palaka","year":"2020","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ekir.2020.10.035_bib33","first-page":"35","article-title":"Function and regulation of transferrin and ferritin","volume":"35","author":"Ponka","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ekir.2020.10.035_bib34","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib35","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2215\/CJN.01390406","article-title":"The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?","volume":"1","author":"Kalantar-Zadeh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000445424","article-title":"High ferritin level and malnutrition predict high risk of infection-related hospitalization in incident dialysis patients: a Japanese prospective cohort study","volume":"42","author":"Kato","year":"2016","journal-title":"Blood Purif"},{"key":"10.1016\/j.ekir.2020.10.035_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2014.114","article-title":"Association between hemoglobin variability, serum ferritin levels, and adverse events\/mortality in maintenance hemodialysis patients","volume":"86","author":"Kuragano","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib38","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jvs.2009.12.068","article-title":"Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial","volume":"51","author":"Depalma","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ekir.2020.10.035_bib39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10157-014-1074-y","article-title":"Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients","volume":"19","author":"Lien","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0021-9150(02)00233-2","article-title":"Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women","volume":"165","author":"Williams","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2020.10.035_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-483","article-title":"Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies","volume":"14","author":"Abril-Ulloa","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib42","doi-asserted-by":"crossref","first-page":"e3547","DOI":"10.1371\/journal.pone.0003547","article-title":"Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload","volume":"3","author":"Brudevold","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.10.035_bib43","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/diacare.27.10.2422","article-title":"Serum ferritin and risk of the metabolic syndrome in U.S. adults","volume":"27","author":"Jehn","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2020.10.035_bib44","first-page":"13317","article-title":"Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis","volume":"8","author":"Jin","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000478735","article-title":"Serum ferritin variations and mortality in incident hemodialysis patients","volume":"46","author":"Kim","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib46","doi-asserted-by":"crossref","first-page":"5490963","DOI":"10.1155\/2017\/5490963","article-title":"Assessing the association between serum ferritin, transferrin saturation, and C-reactive protein in Northern Territory Indigenous Australian patients with high serum ferritin on maintenance haemodialysis","volume":"2017","author":"Majoni","year":"2017","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ekir.2017.09.005","article-title":"Trimethoprim+sulfamethoxazole reduces rates of melioidosis in high-risk hemodialysis patients","volume":"3","author":"Majoni","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2020.10.035_bib48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2014.228","article-title":"Melioidosis and end-stage renal disease in tropical northern Australia","volume":"86","author":"Chalmers","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1515\/CCLM.2002.059","article-title":"Reference values for a heterogeneous ferritin assay and traceability to the 3rd International Recombinant Standard for Ferritin (NIBSC code 94\/572)","volume":"40","author":"Hamwi","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196576","article-title":"Performance and comparability of laboratory methods for measuring ferritin concentrations in human serum or plasma: a systematic review and meta-analysis","volume":"13","author":"Garcia-Casal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.10.035_bib51","series-title":"WHO Guideline on Use of Ferritin Concentrations to Assess Iron Status in Individuals and Populations","year":"2020"},{"key":"10.1016\/j.ekir.2020.10.035_bib52","series-title":"ANZDATA 42nd Annual Report 2019 (Data to 2018)","article-title":"Australia and New Zealand Dialysis and Transplant Registry (ANZDATA): End Stage Kidney disease in Aboriginal and Torres Strait Islander Australians","year":"2019"},{"key":"10.1016\/j.ekir.2020.10.035_bib53","first-page":"108","article-title":"Interesting times\u2014evolution of dialysis in Australia\u2019s Northern Territory (1980\u20132014)","volume":"14","author":"Gillian Gorham","year":"2018","journal-title":"RSA J"},{"key":"10.1016\/j.ekir.2020.10.035_bib54","series-title":"Aboriginal and Torres Strait Islander Health Performance Framework 2017 Report","year":"2017"},{"key":"10.1016\/j.ekir.2020.10.035_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5694\/j.1326-5377.1997.tb140103.x","article-title":"The prevalence of hookworm infection, iron deficiency and anaemia in an aboriginal community in north-west Australia","volume":"166","author":"Hopkins","year":"1997","journal-title":"Med J Aust"},{"key":"10.1016\/j.ekir.2020.10.035_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","article-title":"Diagnosis and management of iron deficiency anaemia: a clinical update","volume":"193","author":"Pasricha","year":"2010","journal-title":"Med J Aust"},{"issue":"suppl","key":"10.1016\/j.ekir.2020.10.035_bib57","first-page":"S13","article-title":"Anaemia in Yirrkala","volume":"144","author":"Watson","year":"1986","journal-title":"Med J Aust"},{"key":"10.1016\/j.ekir.2020.10.035_bib58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-3156.2003.01158.x","article-title":"Soluble transferrin receptor in Aboriginal children with a high prevalence of iron deficiency and infection","volume":"9","author":"Ritchie","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1753425914553645","article-title":"Effects of gender, cytokine gene polymorphisms and environmental factors on inflammatory responses","volume":"21","author":"Moscovis","year":"2015","journal-title":"Innate Immun"},{"key":"10.1016\/j.ekir.2020.10.035_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2334-12-249","article-title":"Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.ackd.2004.10.015","article-title":"Interfaces between cardiovascular and kidney disease among Aboriginal Australians","volume":"12","author":"McDonald","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib62","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/ajr.12044","article-title":"Diabetic major amputation in Far North Queensland 1998-2008: what is the Gap for Indigenous patients?","volume":"21","author":"O'Rourke","year":"2013","journal-title":"Aust J Rural Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2014.02.015","article-title":"Associations between periodontal disease and cardiovascular surrogate measures among Indigenous Australians","volume":"173","author":"Kapellas","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2020.10.035_bib64","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/dc17-1919","article-title":"High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in indigenous Australians with diabetes: the eGFR follow-up study","volume":"41","author":"Barr","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ekir.2020.10.035_bib65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1186\/1471-2458-11-729","article-title":"The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study","volume":"11","author":"Skilton","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clinbiochem.2016.11.024","article-title":"Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtration rate in Indigenous Australians: the eGFR study","volume":"50","author":"Barr","year":"2017","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ekir.2020.10.035_bib67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/nep.12841","article-title":"The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community\u2014a prospective cohort study","volume":"22","author":"Arnold","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2020.10.035_bib68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1440-1754.2004.00422.x","article-title":"Iron deficiency in minority groups in Australia","volume":"40","author":"Brewster","year":"2004","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ajr.12338","article-title":"Anaemia in school-aged children in an Australian Indigenous community","volume":"25","author":"Udovicich","year":"2017","journal-title":"Aust J Rural Health"},{"key":"10.1016\/j.ekir.2020.10.035_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10245330410001714176","article-title":"The haematology of indigenous Australians","volume":"9","author":"Erber","year":"2004","journal-title":"Hematology"},{"key":"10.1016\/j.ekir.2020.10.035_bib71","series-title":"Nutrition in Aboriginal and Torres Strait Islander Peoples","year":"2000"},{"key":"10.1016\/j.ekir.2020.10.035_bib73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1756283X11398736","article-title":"Diagnosis and management of iron deficiency anemia in the 21st century","volume":"4","author":"Johnson-Wimbley","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib74","first-page":"S21","article-title":"Markers of iron status in chronic kidney disease","volume":"21","author":"Gaweda","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","article-title":"2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease","volume":"3","author":"Yamamoto","year":"2017","journal-title":"Renal Replace Ther"},{"key":"10.1016\/j.ekir.2020.10.035_bib76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hdi.12078","article-title":"TSAT is a better predictor than ferritin of hemoglobin response to epoetin alfa in US dialysis patients","volume":"18","author":"Gaweda","year":"2014","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib77","doi-asserted-by":"crossref","first-page":"s12","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0012","article-title":"Iron status as measured by serum ferritin: the marker and its limitations","volume":"34","author":"Cavill","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib78","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/clinchem\/48.7.1066","article-title":"Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency","volume":"48","author":"Thomas","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2020.10.035_bib79","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood.V126.23.955.955","article-title":"Serum ferritin is not sensitive or specific for the diagnosis of iron deficiency in patients with normocytic anemia","volume":"126","author":"Ho","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2020.10.035_bib80","series-title":"Aboriginal and Torres Strait Islander Health Performance Framework 2017 Report: Northern Territory","year":"2017"},{"key":"10.1016\/j.ekir.2020.10.035_bib81","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ndt\/12.6.1173","article-title":"Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients","volume":"12","author":"Braun","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.035_bib82","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0272-6386(97)90104-9","article-title":"Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO","volume":"30","author":"Mittman","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2020.10.035_bib83","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/00365510500206542","article-title":"Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease","volume":"65","author":"Markovic","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ekir.2020.10.035_bib84","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2215\/CJN.02190309","article-title":"Hepcidin for clinicians","volume":"4","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib85","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ndt\/17.6.1063","article-title":"Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients","volume":"17","author":"Tarng","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib86","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12, pt 2","key":"10.1016\/j.ekir.2020.10.035_bib87","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/j.lpm.2017.10.006","article-title":"Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease","volume":"46","author":"Daher","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib88","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2215\/CJN.05990809","article-title":"Current status of the measurement of blood hepcidin levels in chronic kidney disease","volume":"5","author":"Macdougall","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.krcp.2013.01.001","article-title":"Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease","volume":"32","author":"Larson","year":"2013","journal-title":"Kidney Res Clin Pract"},{"issue":"12, pt 2","key":"10.1016\/j.ekir.2020.10.035_bib90","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.lpm.2017.09.028","article-title":"Diagnosis of hyperferritinemia in routine clinical practice","volume":"46","author":"Lorcerie","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib91","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bjh.15083","article-title":"The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients","volume":"180","author":"Ricchi","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2020.10.035_bib92","first-page":"BC11","article-title":"Association of serum ferritin levels with metabolic syndrome and insulin resistance","volume":"9","author":"Padwal","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.ekir.2020.10.035_bib93","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/jc.2008-1159","article-title":"Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese","volume":"93","author":"Sun","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2020.10.035_bib94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1467-789X.2008.00545.x","article-title":"Prevalence of obesity and metabolic syndrome in Indigenous Australian youths","volume":"10","author":"Valery","year":"2009","journal-title":"Obes Rev"},{"issue":"12, pt 2","key":"10.1016\/j.ekir.2020.10.035_bib95","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.lpm.2017.10.008","article-title":"MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders","volume":"46","author":"Paisant","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib96","first-page":"17","article-title":"Histological scores validate the accuracy of hepatic iron load measured by signal intensity ratio and r2\u2217 relaxometry MRI in dialysis patients","volume":"9","author":"Rostoker","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib97","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02045","article-title":"Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations","volume":"5","author":"Rostoker","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.ekir.2020.10.035_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132006","article-title":"Reassessment of iron biomarkers for prediction of dialysis iron overload: an MRI Study","volume":"10","author":"Rostoker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2020.10.035_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nep.12735","article-title":"Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis","volume":"22","author":"Holman","year":"2017","journal-title":"Nephrology"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2020.10.035_bib101","first-page":"S58","article-title":"Diagnosing and preventing iron overload","volume":"21","author":"Ramanathan","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gft269","article-title":"Iron toxicity: relevance for dialysis patients","volume":"29","author":"Fishbane","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2020.10.035_bib103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/sdi.12168","article-title":"Iron and infection in hemodialysis patients","volume":"27","author":"Ishida","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.ekir.2020.10.035_bib104","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2020.10.035_bib105","first-page":"32","article-title":"The relation between body iron store and ferritin, and coronary artery disease","volume":"10","author":"Pourmoghaddas","year":"2014","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.ekir.2020.10.035_bib106","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the dialysis patients\u2019 response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib107","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1681\/ASN.2007050606","article-title":"Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin","volume":"19","author":"Kapoian","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib108","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2215\/CJN.03970318","article-title":"Safety of dynamic intravenous iron administration strategies in hemodialysis patients","volume":"14","author":"Li","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2020.10.035_bib109","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ndt\/gfx381","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease","volume":"34","author":"Chinnadurai","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"12, pt 2","key":"10.1016\/j.ekir.2020.10.035_bib110","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/j.lpm.2017.05.036","article-title":"Dysmetabolic iron overload syndrome (DIOS)","volume":"46","author":"Deugnier","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.ekir.2020.10.035_bib111","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ebiom.2018.11.020","article-title":"Liver iron load influences hepatic fat fraction in end-stage renal disease patients on dialysis: a proof of concept study","volume":"39","author":"Rostoker","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ekir.2020.10.035_bib112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2019.01.005","article-title":"Treatment of anaemia in end-stage renal disease: a double-edged iron sword?","volume":"40","author":"Chinnadurai","year":"2019","journal-title":"EBioMedicine"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492031706X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492031706X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:35:33Z","timestamp":1762832133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802492031706X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S246802492031706X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2020.10.035","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2020.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}